ANNA GOULD: Open Payments
NPI 1790392157 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,760 in 101 payments from 25 companies in 2025. Trend: 2023 $2,549 · 2024 $2,474 · 2025 $3,760
Food & beverage: $3,558Education: $202
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $997 |
| UCB, Inc. | 11 | $431 |
| GENZYME CORPORATION | 7 | $301 |
| ABBVIE INC. | 7 | $239 |
| Arcutis Biotherapeutics, Inc. | 11 | $227 |
| Janssen Biotech, Inc. | 6 | $190 |
| LEO Pharma Inc. | 4 | $164 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $146 |
| Galderma Laboratories, L.P. | 7 | $144 |
| MERZ NORTH AMERICA, INC. | 1 | $131 |
Products named: DUPIXENT, Bimzelx, TREMFYA, BOTOX, NEMLUVIO, EBGLYSS, Winlevi, SOFDRA.
Industry payments across AZ — which companies pay providers there.
